The US Centers for Medicare & Medicaid Services (CMS) has granted Medtronic plc, a global healthcare technology leader, transitional pass-through (TPT) payment status for its Symplicity Spyral renal denervation (RDN) catheter. This recognition, under the Medicare Hospital Outpatient Prospective Payment System, is set to be effective from January 1, 2025, for up to three years, […]
Medtronic has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting approval for its Affera Mapping and Ablation System, including the Sphere-9 catheter. This approval, announced on 24 October 2024, positions Medtronic as the first and only company to offer dual-energy pulsed field ablation (PFA) and radiofrequency (RF) technologies for atrial […]
In a significant development for varicose vein treatment, Medtronic Private Limited and SWIZTON Medcare have unveiled their first vein clinic in Bengaluru. This strategic collaboration aims to revolutionise the treatment landscape for varicose veins by combining Medtronic’s advanced medical solutions with SWIZTON Medcare’s healthcare expertise. The inaugural event took place at Aveksha Hospital in Singapura, […]
Medtronic plc (NYSE: MDT), a leader in healthcare technology, presented compelling new data at the American Diabetes Association’s (ADA) 84th Scientific Sessions, highlighting the MiniMed 780G system’s efficacy in managing hyperglycemia and reducing nighttime burden for individuals with chronic inflammatory demyelinating polyneuropathy (CIDP). This data adds to the growing body of evidence that the MiniMed […]
Medtronic plc (NYSE: MDT), a leader in healthcare technology, announced breakthrough results at the Heart Rhythm Society (HRS) 2024 Annual Meeting for its Affera Mapping and Ablation System with Sphere-9 Catheter. This system, designed for the treatment of persistent atrial fibrillation (AFib), has demonstrated significant safety and efficacy in the SPHERE Per-AF study, a pivotal […]
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced a significant advancement in the treatment of chronic pain with the U.S. Food and Drug Administration (FDA) approval of its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). This device represents a major leap forward in pain management technology, featuring the first-of-its-kind closed-loop system […]
Medtronic plc (NYSE: MDT), a global frontrunner in medical technology, has recently unveiled compelling new clinical and real-world evidence regarding the MiniMed 780G system, marking a significant advancement in diabetes management technology. Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Florence, Italy, this evidence underscores the system’s efficacy […]
Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company, for a total consideration of KRW 971 billion ($738 million). This acquisition marks Medtronic’s move to expand its capabilities in addressing the needs of individuals with diabetes. South Korean medical device innovation in diabetes care Founded in […]
Zydus Hospitals, Ahmedabad, and India Medtronic Private Limited, a fully-owned affiliate of American medical devices maker Medtronic announced a collaboration to help patients suffering from a stroke in Gujarat through a hub-and-spoke network. As part of this partnership, India Medtronic will collaborate with Zydus Hospitals to build an environment that can aid in the prompt […]
Medtronic said that it has been issued a warning letter from the US Food and Drug Administration (FDA) for its facility in Northridge, California, which serves as the headquarters for its diabetes business. The warning letter is the result of an inspection concluded by the FDA in July 2021 pertaining to recalls of the MiniMed […]